Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

The New England Journal of Medicine
C A CHIDSEYE BRAUNWALD

Abstract

No abstract listed.

References

Sep 10, 1952·Acta Physiologica Scandinavica·U S VON EULER, S HELLNER
Dec 15, 1958·Acta Physiologica Scandinavica·A BERTLERE ROSENGREN
Apr 18, 1959·British Medical Journal·K W DONALD
Jul 1, 1959·Circulation Research·R F RUSHMERD FRANKLIN
Feb 1, 1961·Acta Physiologica Scandinavica·U von EULER, F LISHAJKO
Nov 1, 1961·Circulation Research·J H SIEGELS J SARNOFF
Jun 1, 1952·British Journal of Pharmacology and Chemotherapy·A S OUTSCHOORN, M VOGT

❮ Previous
Next ❯

Citations

Jan 1, 1970·Journal of Surgical Oncology·J W MostertG P Murphy
Nov 1, 1996·Cardiovascular Drugs and Therapy·R FerrariO Visioli
Jan 1, 1974·European Journal of Clinical Pharmacology·F VillaniJ L Schelling
Feb 1, 1994·Cardiovascular Drugs and Therapy·L Demopoulos, T H LeJemtel
Jun 1, 1994·Cardiovascular Drugs and Therapy·P Harris
Apr 1, 1995·Cardiovascular Drugs and Therapy·V PanfilovG Olsson
Jan 23, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Masue YohToshiji Iwasaka
Jan 23, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Myron C GersonRonald W Millard
Mar 1, 1965·The American Journal of Medicine·J R GILLF C BARTTER
Sep 1, 1965·The American Journal of Medicine·C A CHIDSEYA G MORROW
Jul 1, 1981·The American Journal of Medicine·W S ColucciE Braunwald
Jan 1, 1982·Pharmacology & Therapeutics·K O Haustein
Jan 1, 1983·Pharmacology & Therapeutics·W H Newman
Jun 15, 1991·Journal of the Autonomic Nervous System·J IkedaT Takishima
Sep 1, 1989·Journal of the American College of Cardiology·J A Franciosa, D E Schwartz
Oct 1, 1991·Journal of the American College of Cardiology·M Jessup
Mar 1, 1994·Journal of the American College of Cardiology·S L Beau, J E Saffitz
Jun 11, 2005·Journal of Cardiac Failure·Andrew L Clark, John G F Cleland
Dec 9, 2003·Trends in Biochemical Sciences·Xander H T Wehrens, Andrew R Marks
Jul 20, 2002·International Journal of Cardiology·Masatoshi FujitaBrian Budgell
Aug 7, 2002·International Journal of Cardiology·Wolfram Doehner, Stefan D Anker
Aug 7, 2002·International Journal of Cardiology·Stefan D Anker, Rakesh Sharma
Apr 5, 2000·International Journal of Cardiology·K MatsuyamaT Yoshioka
Aug 9, 2003·Journal of the American College of Cardiology·Chang-seng Liang
Sep 6, 2003·Journal of the American College of Cardiology·Fabiana RovedaCarlos Eduardo Negrão
Jan 1, 1983·Journal of the American College of Cardiology·K Chatterjee, W W Parmley
Sep 1, 1983·Journal of the American College of Cardiology·M T OlivariJ N Cohn
Apr 1, 1985·Journal of the American College of Cardiology·G S FrancisJ N Cohn
Sep 26, 1963·The New England Journal of Medicine·C A CHIDSEYD T MASON
Aug 20, 1964·The New England Journal of Medicine·J G PITTMAN, P COHEN
Apr 14, 1966·The New England Journal of Medicine·W J PhillipsR Paine
Nov 9, 1967·The New England Journal of Medicine·E BraunwaldE H Sonnenblick
Oct 14, 1971·The New England Journal of Medicine·D L EckbergE Braunwald
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Jun 2, 2001·The New England Journal of Medicine·E Braunwald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.